The decision to stop hydroxychloroquine’s use in the Solidarity trial does not apply to the use or evaluation of hydroxychloroquine in pre or post-exposure prophylaxis in patients exposed to COVID-19.
6304
什么是团结试验？
What is the Solidarity Trial?
6305
团结试验是一项国际临床试验，由世卫组织和合作伙伴发起，旨在帮助找到COVID-19的有效疗法。
The Solidarity Trial is an international clinical trial to help find an effective treatment for COVID-19, launched by WHO and partners.
6306
希望正在接受试验的一种或多种疗法最终将改善COVID-19患者的临床结局并挽救生命。
It is hoped that one or more of the treatments under trial will result in improving clinical outcomes in COVID-19 patients and save lives.
6307
除团结试验外，世界各地也在进行其他试验。
Other trials are on-going around the world in addition to the Solidarity Trial.
6308
治疗方案有：瑞德西韦；
The treatment options are: Remdesivir; Lopinavir/Ritonavir; and Lopinavir/Ritonavir with Interferon beta-1a.
6309
洛匹那韦/利托那韦；
The treatment options were originally selected based on evidence from laboratory, animal and clinical studies.
6310
以及洛匹那韦/利托那韦和干扰素β-1a。
Hydroxychloroquine was originally included in the trial but this arm was stopped, as of 17 June 2020, as evidence showed it did not result in the reduction of mortality of hospitalised COVID-19 patients, when compared with standard of care.